arrow
E

Eduard Vieta

instituto de salud carlos iii
H指数:153
被引数:10.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Meta-Analytic Evidence of Clinical, Cognitive, Biological and Treatment Characteristics of Bipolar Spectrum Disorder in Children and Adolescents: Results From an Umbrella Review

关于儿童和青少年双相谱系障碍的临床、认知、生物学和治疗特征:伞形综述的结果

2026-10-200
OAAI
Nutraceuticals and phytoceuticals in the treatment of bipolar disorder: A systematic review and network meta-analysis

营养保健品和植物保健品在双相情感障碍治疗中的应用:一项系统综述和网络荟萃分析

2026-10-050
PRE
Refining the young mania rating scale: Accelerating development of psychopathology measures joint ISCTM/ECNP bipolar working group consensus

优化青年躁狂评分量表:精神病理学测量工具的加速发展——联合ISCTM/ECNP双相工作小组共识

2026-09-190
OAAI
Cognitive profiles in first-episode psychosis: the impact of genetics, environment, and cognitive reserve as risk and protective factors.

首发病症精神分裂症的认知特征:遗传、环境及认知储备作为风险和保护因素的影响。

2026-09-020
PRE
The Association Between Lithium Use and Physical Comorbidities Across Age Groups: A Cross-Sectional Study From the Global Aging and Geriatric Experiments in Bipolar Disorder (GAGE-BD) Project

锂使用与不同年龄组间躯体合并症的关联:一项来自双相障碍全球老龄化和老年医学实验(GAGE-BD)项目的横断面研究

2026-08-300
PRE
Longitudinal Motor Trajectories and 2-Year Cognitive and Functional Outcomes in First-Episode Psychosis

首发精神病患者纵向运动轨迹及2年认知与功能结局

2026-08-250
PRE
Sedentary Behavior and Physical Activity in Individuals With Bipolar Disorder: An Evidence Synthesis and Position Statement From the ISBD Nutrition and Exercise Task Force (NExT)

双相障碍患者中的久坐行为和身体活动:ISBD营养与运动工作组(NExT)的证据综合和立场声明

2026-08-170
OAAI
Towards a Safe and Effective Lithium Therapeutic Range for Older Adults With Bipolar Disorder: An ISBD Task Force Systematic Review

为伴有双相障碍的老年患者制定安全有效的锂治疗剂量范围:一项ISBD任务小组系统综述

2026-08-170
OAAI
Prescription Trends for Bipolar Disorder With and Without Comorbid Substance Use and Anxiety Disorders: A Global Bipolar Cohort Collaborative Study

双相障碍合并与不合并物质使用及焦虑障碍的处方趋势:一项全球双相障碍队列协作研究

2026-08-170
PRE
Validation of the SPF-10: A new scale for assessing self-perceived functioning in schizophrenia. The VALFASS study (vol. 201, pg. 526, 2026)

SPF-10量表的验证:一种用于评估精神分裂症患者自我感知功能的新量表。VALFASS研究(卷201,页526,2026)

2026-08-010
PRE
Clinical guidance on the use of esketamine nasal spray for patients with treatment resistant depression: A European Delphi consensus report

关于 esketamine 鼻喷雾剂在难治性抑郁症患者中使用的临床指南:一项欧洲 Delphi 共识报告

2026-07-170
OAAI
Validation of the SPF-10: A new scale for assessing self-perceived functioning in schizophrenia. The VALFASS study

SPF-10量表的验证:一种用于评估精神分裂症患者自我感知功能的新量表。VALFASS研究

2026-07-011
PRE
Functioning assessment short test for autism (FAST-A): a tool to evaluate adaptive functioning in autistic adults (Vol 112, 112887, 2026)

孤独症功能评估简短测试(FAST-A):用于评估孤独症成人适应功能的工具(卷112,112887,2026)

2026-07-010
OAAI